ArticleAnnals of hematology2026

Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias.

Xiao Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.